Council for Tobacco Research
the Cancer Letter; Vol 4 No42
Fields
- Type
- NEWSLETTER
- ABSTRACT
- Depository Date
- 29 Mar 1996
- Named Person
- Devita, V.
- Nci
- Hew
- Natl Cancer Advisory Board
- Nih
- Hew Appropriations Subcomm
- Northern, C.A. Oncology Group
- Natl Cancer Treatment Group
- Ultmann, J.
- Hoogstarten, B.
- Decosse, J.
- Cancer Clinical Investigation Review Comm
- Muggia, F.
- Salmon, S.
- Rubin, P.
- Gray, N.
- Napalkov, N.P.
- Hirayama, T.
- Abbatucci, J.S.
- Lissaios, B.
- Hellenic Cancer Society
- Ngu, V.A.
- Jussawalla, D.J.
- Brazilian Cancer Society
- Cancer Letter
- Barg, S.
- Veronese, U.
- Denoix, P.
- Amnesty Intl
- Kaplan, H.
- Stanford Univ
- Cox, R.
- Buenos Aires Herald
- Esteban, E.
- Renaudi, L.
- Litwark, M.
- Abbott, D.
- Simpson, H.
- Yale Univ
- Inst For Cancer Research
- Univ, T.X.
- Univ Southern, C.A.
- Oh State Univ
- List, O.F. Nci Contractors
- Brooke, E.
- Cameroun
- Nci
- Request
- 135
- Author
- Cancer Letter
- Box
- 134
- Site
- Zahn
- UCSF Legacy ID
- anv2aa00
Document Images
I
P.O. BOX 2370 RESTO,N,1rIRGINIA TELEPHONE 703-520-4646
COOPERATIVE GROUP REORGANIZATION TO BE OFFERED
BY DEVITA AT CLINICAL TRIALS REVIEW NEXT MARCH
Vincent DeVita, directoR of NCI's Div. of Cancer Treatment, will ptlo-
pose a major reorganization of the Cooperative Groups at the clinical
~tQ~fe (Continued to page 2)
NCI G ETS $937 MI LLION FOR FY 79 AS CONGRESS
ADJOURNS; CANCER ACT RENEWED FOR TWO YEARS
CONGRESS MANAGED to complete action in the last hectic days
before adjourning on the two major bills affecting the Cancer Program-
HEW appropriations and renewal of the National Cancer Act. First, the
1979 fiscal year money bill: NCI wil! get S937 million, assuming that
it receives 520 million for training programs as :xpected by NCI execu-
tives. Congress did not get around to acting on a new training authoriza-
tion bill but will when the new Congress meets next year. They
probably will be funded with a supplemental appropriation early in the
new Congress. The House had voted SSSS million for NCI, plus train-
ing. The Senate HEIC Appropriations Subcommittee had approved
S950 million, pius training, but thc full Appropriaticns comaniltee
chopped that by S25 million. When the bill reached the Senate floor,
Birch Baylt succeeded in restoring half the cut, sending a figure of
S937.5 plus training to thr conference with the House. Sen. Edward
Brooke led the fight for thc Cancer Program, getting the Iloukc con-
ferees to agree to S917 million. which was S4 million more than a50-
Sq split.,... CANCER:ICT RE:CEW:vL: The contpromise bill ea-
tended the National Cancer Act for two years: authorized S9'.).5 and
S103 million for Cancer Control, 5924.5 and S927 million for the rest
of NCI; approved tiie distribution of chemicals and other research
materials and test animals to grantees as well as contractors; retained as
Presidential appointees members of the National Cancer Advisory Board
and the NCI director; accepted the amendment in the House bill autho-
rizing NCI's Cancer Control Proram to support expanded community
programs: modified the House proposal requiring \CI to publish an
annual report of known and suspected carcinogens and their regulatory
status. conferring instead that task to the HEWsecretary: requires that
five members of the hCAl3 be experts in environmental carcinogenesis
and two be active in treating cancer patients: encourages research in
low level radiation effects and intensified efforts in environmental and
occupatior.al causes of cancer: adds basic research to official mission of
cancer centers. Except for a few other minor changes, the Cancer Act
remains as it was renewed in [974.. .. HSA AUTHORIZATION bill,
extending the Health Planning Act, with months of work by both
,h,Cn,Ps. went dn..n the drain: Congress instead passed a straight one
year renewal "as is." Cancer Program lobbyist Nathanial Polster had
succeeded in getting both houses to accept amendment eliminating
most NIH research and demonstration programs from HSA authority.
That effort now will have to be repeated next year.
QW-
ti
Hum~
.-..,,~n
na
n
; .rtrgntt vioumosss~~.~;..
, :. -~ ~:-
Contiriue, But Eome"`~'-
evl-.G.
Improvement Seen ;
:
,
,,- ,
P
~.
R FA Announced
r Or. Models e=or,'-'
Planniny Comrnunicjr
a. " . ..... .. . .t,: .
Prsvention Fropram...aAL.
JS_YS;-
~
~ - .. . . _ , .. .
Sources Sought,
R FPs Available
. . . Page 6
Contract Awards
... Page 8
27
(~ Z N

D'EVITA TO PROPOSE REORGANIZATION
OF COOPERATIVE GROUPS BY REGIONS
(Continued from page 1)
trials review before the DCT Board of Scientific
Counselors next March 26-28.
DeVit2's proposal will be to reshape the existing
groups into regional or geographical 'entities, along
the lines of the Northern California Oncology Group
or the North Central Cancer Treatment Group. The
groups would work independently using theia own
protocols, and together when a larger multi-institu-
tional effort is required.
"This isn't anything new. I've beeft talking about
it for quite some time," DeVita said. "I don't want
anyone to think we've made up our minds that this
is the way it will be. I'm just going to open the meet-
ing with this as a proposal, and give them something
to shoot at. After heating all the presentations, the
Board may feel that everything is fine and we should
leave it just the way it is."
DCT Board Chairman John Ultmann reported at
this week's meeting of the Board that he had met
with Barth Hoogstraten. former chairman of the
Group Chairmen's Committee: Jerome DeCosse,
chairman of the Cancer Clinical Invest:gation Review
Committee; and Franco 14uggia, chief of DCT's
Cancer Therapy Evaluation Program, to work out the
agenda for the first two days of the ineeting. The
final day will be reserved for Board consideration of
the presentations, any actioa it may, decide to take
on DeVita's proposal, and other business.
At their meeting last June. Cooperative Group
chairmen rejected the meeting agenda proposed by
DCT staff and objected to the selection by DeVita of
speakers making the Group presentations (TheCancer
Letter, Jhne 30). Those issues have been resolved,
Ultmann reported, with both agenda and speakers
agreeable to all concerned.
The meeting will review the progress of clinical
cancer research over the past 20 years, with the pni-
pose oi providing DCT and its Board with a basis for
determining how clinical research will be conducted
in the future.
Cooperative Group chairmen have been apprehen-
sive about the review and its conseqttences. Some feel
the DCT Board is anti-Group.
"We will cover the success areas and highlight the
problem areas," Ultmann told the Board. "We hope
it will give a balanced view of what has been accom-
plished in the last 20 years, and give us a basis for
funding'clinical research in the next, 10 years."
Board member Henry Kaplan, a Cooperative Group
critic, ccimmerued that Groups have conducted "what
I call 'me-too' trials, that have added trivial data and
accomplished essentially nothing. 1t'ill we be pre-
sented with a true idea of what has been accom-
plished in light of all the money spent?"
"We'll try to present a balanced agenda." was I)e-
Thet Cancer Letter Oct. 20, 1978 / Page 2
Vita's response. Aluggia said the overview would be
limited to five disea'se sites. Discussion w;il include
special problems and needs of clinical trials.
The review also will include clinical trials sup-
ported by NCI contracts. "I didn't hear where single
institution developments will be evaluated," said
Board member Sydney Salmon. "This will be primari-
ly Cooperative Groups and contractors. The contri-
butions of single ir.stitutions with grants have been
under-reported."
"We have a section in tiie agenda for it, although
the speaker has not yet been selected," Ultmann said.
"One overriding need in clinical r:.search is ideas,"
Kaplan said. "There has been a paucity of ideas from
Cooperative Groups and contractors. Most ideas
have come from individual institutions."
Board member Philip Rubin was both a defender
and critic of the Groups. "I'm a card carrying
member (of a Group) so I can say this. Cooperative
Groups are like dinosaus running around. We need
to redefine the mechanism." Rubin said the Groups
play an important role, as a "shakedown mechanism,
a confirmatory process to see if a method can work
in multiple institutions, with multiplc physicians."
DeVita said he was "suspect when it comes to
Cooperative Groups. I think I've been fair." He
pointed out that since the Cooperative Group Pro-
gram was moved to DCT, its budget has increased by
40%.
Ultmann said first that no time would be
scheduled at the March meeting for the Board to act
on any recommendations coming out of the presenta-
tions. "That probably will be spread over the next
several Board meetings," DeVita said.
Kaplan objected. "We shouldn't delay action," he
said. "Memories fade, people rotate on and off this
Board. We should obliterate other items and devote
the last day to consideration of actions. We will never
be better informed than we will then."
DeVita said he hoped the Board at least would act
on his proposal for reorganizing the Groups.
If the Board accepted DeVita's plan, it would be
phased in over a fairly lengthy period of time. DeVita
believes it would not mean existing Groups would go
out of business but that their membership would be
considerably changed. One result would be elimina-
tion of multigroup membership at individual institu-
tions, a practice DeVita feels is wasteful and some-
times disruptive.
Another would be, if the Northern California and
North Central examples are followed, an increase in
the number of community physicians in Cooperative
Group tnembership. This possibly could make it
easier to accrue greater numbers of patients in
studies. And if the contention is true that the best
cancer treatment is that which is done in research
protocols. then another result could be improvement
of the quality of treatment at the community level.
I ~- Z N 3Q28-

CONGRES.c DEMONSTRATES WERNATIONAL
FALLOUT FROM CANCER PROGRAM IN U.S.
BUENOS AIRES-The United State National
Cancer Program has captured the imagination and
fired the enthusiasm-'-as perhaps nothing else has ever
done-of clinicians and scientists arotlnd the world.
This enthusiasm reaches far beyond the limited sup-
port NCI provides foreign pro,iects. U.S. dollars have
practically nothing to do with the intense interest in
cancer research and r,ontrol generated in the 77
countries which sent representatives to the Xl1th In-
ternational Cancer Congress, With the stimulation
provided by the International Union Against Cancer,
momentum has been generated that is commanding
increasing shares of national effort in developed and
undeveloped nations alike.
This positive fallout from the National Cancer Pro-
gram was evident here at the Congress, attended by
more than 8,100 professionals and non-professionals
from around the world. The attendance was a record,
approaching an increase of 50% over the last Congress
in Florence.
Registrants included 7,200 A1Ds, PhDs and nurses,
and 800 associate members. About half of the at-
tendees were from Latin America, with 3.300 from
Argentina alone. The U.S had the second largest
delegation, 900, with 600 from Japan. more than 200
each from Canada, Germany, Great Britain and
Brazil, and more than 100 each from France, Spain,
B~lgiu:n and Italy.
It was obvious that the rest of the world is closely
following the Cancer Program in the States. and many
of the countries are reacting to developments. Many
may lack the facilities and manpowet to follow up
effectively on these developments, but most appear
to be working hard to overcome those deficiencies.
They seem to know the latest protocols, and imple-
ment them when they can. They follow, in the liter-
ature and in discussions with U.S. colleagues. develop-
ments in basic research and try to add their bit to
fundamental understanding of cancer. They are
offering some unique and important contributions of
their own, particularly in cancer epidemiology.
Perhaps the most interesting application of U.S.
Cancer Program developments reported on here is in
canccr control. Not all countries can participate in
sophisticated research, but even the poorest can ini-
tiate some effort in control. \1'hat they do take up,
it seems, has been based on what they have heard
about control programs in the U.S.
Most countries IoQk to cheaper methods of cancer
control, ruch as the Pap smear and education toward
breast self examination while rejecting more expen-
sive mass screening programs. Atost qre concerned
about the cigarette problem but are perplexed over
what to do about it.
Nigel Gray. Australia, said at a cancer control
.cirn that 4 11: of the Australian male population
smokes but that 22% of the males are ex-smokers,
which he credited to a public education program.
His country has been able to elZminate high tar
brands (cver 22 mg), Gray said; with the range from
5 to 22.
A Venezuela physician asked that UICC reaffirm
its resolution passed eight years ago against smoking.
"We need to put some pressures against our go..rn-
ment, which resists antismokirag efforts because it
receives so much revenue from cigarette taxesv" he
said. "FiE'ty percent of our population is under 20,
and they see on television constant propaganda for
smoking, and nothing against it:"
N.P. Napalkov, who-heads cancer control activities
in the Soviet Union, said his country has banned all
tobacco advertising and prohibits smoking in mass
transportation but that it has riiot decreased cigarette
sales. There are special educatidn progzams in high
schools, "but I confess we are ss inefficient as other
countries. As long as you have,boys and girls kissing
on the screen between puffs of cigarettes, such pro-
grams are not successful."
Takeshi Hirayama, Japan, described a contrbl pro-
gram against liver cancer in his country. Based on the
belief that viral hepatitis B eventually becomes hepa-
tocarcincbma, the program is airned at intervening in
the transfer of the virus, preventing transfer frbm
mother to babies, and accidentttl.infection, particu-
larly in hospitals and blood transfusions. Hospital
persor+-nel and medical staff are carefully monitored,
with staff examined 12 ti:nes a year, Hirayama said.
J.S. Abbatucci, France, said that prevention pro-
grams there related to alcohol include public educa-
tion. a sales tax on liquor, random tests of drivers for
alcohol cmnsumption, and research to lower alcohol
content of t.everages. France has a program in breast
self examination and recommends cervical smears as
part of pr.maritL: preparations ar.d before prescribing
oral contraceptives.
B. Lissaios, Greece, started a,controversy in one
cancer control session on reaching the "hard to
reach" by commenting that one tool used in Hellenic
Cancer Society outreach efforts is "fear-the easiest,
fastest way to motivate people to come in for exami-
nations."
\'A. Ngu, Cameroun, disagreed. "More fear can
only drive scme beyond our reach. We propose edu-
cation rather than exploitation of fear."
D.J. Jussawalla, India, related what others at the
session described as "clever approaches" to reach vast
numbers of persons with high itliteracy in rural areas-
satellite communications, TV, tadio, films, slide
shows, posters, demonstrations.
A representative of the Brazilian Cancer Society
reported that his country has begun developing a
cancer information telephone network "inspired by
the Roswell Park system."
U.S. scientists at the Congress contacted by Tlre
Cancer Lerrrr generally agreed that there were few
Page 3/ Vol, 4 No. 42 The Ca Cer Let"29
" L ~V

new developments presented, at least not itew ta
them. There were some exceptions. The Japanese,
whb are heavily into development of analogs of
proven anticancer drugs, reported on two which one
American clinical scientist said should be put into
clinical trials in the U.S.-pepleomycin, a bleomycin
analog; and aclacinonaycin A, a derivative of actino-
mycin. Trials in Japan show them apparently less
toxic than the parent drugs and probably at least as
effective.
Other scientists felt that basic research in carcino-
genesis is being done very well at a number of non-
U.S. institutions, as judged by several reports on re-
search into mechanisms of action.
UICC officials, staff and the Argentine hosts did
generally an outstanding job in the planning, organiz-
ing and running of the Congress. The meetings ran
smoothly, although there were some program
changes. and the interpreter system worked without
flaw. The logistics of moving 8,000 persons from the
downtown hotels to the opening ceremonies and to
the major social functions across town were for-
midable, but accomplished with the aid of squadrons
of motorcycle police.
Umberto Veronese of Italy assumed the UICC
presidency at the meeting's conclusion, replacing
Pierre Denaix of France, Seatfle was selected over
Brussels as the host city, for the XIIIth Congress An
1982, after Thailand withdrew its proposal because
it decided it could to provide enough hotel rooms.
HUMAN RIGHTS VIOLATIONS CONTINUE
IN ARGENTINA; IMPROVEMENT NOTED
BUENOS AIRES-There is no question that the
present military government of Argentina has cracked
down hard on its citizens who someone in the govern
memt or military establishment feel are threats to the
regime. Not a single Argentine physician or scientist
who discussed the issue with The Carrcer Letter
denied that people-including many of their col-
leagues-have been arrested and held without trial, or
have simply "disappeared."
Even Salomon Barg, secretary general of the h+ost
organizing committee and an ex-officio spokesman
for the government, admitted there havE been and
may continue to be some arrests.
Almost everyone, however, commented that bad
as it may be now, it is nothing compared with the
situation when terrorists had created a virtual civil
war with bombing, murdering and kidnapping which
struck especially hard at the nation's managerial and
9ntelligencia classes.
"Every day, four, five, ten of my colleagues dis-
appeared," Barg s: id. "Children of my friends were
killed, cars were bombed.lVe were afraid to go on
the streets. It was like Vietnam. a war." Barg is chief
of surgery at a large Buenos Aires hospital.
Was it the terrorists who did the kidnapping, or
was it the government reacting against the terrorists?
The Cancer Letter Oct. 20, 1978 / Page 4
"We didn't know who it was. It was like the Aiafia,`
Barg said he has been told that arrests being made
now frequently are initiated by lower level police
oft3cials acting on their own.lVhen responsible
government officials hear about them, the victims
are either released or brought to trial, Barg said.
Other Argentine physicians, most of whom talked
freely, deplored the fact that the country is run by a
dictatorship. But the situation was so bad before the
coup by the military in 1976 which replaced the Isa-
belle Peron government that there is nearly a uni-
versal feeling of relief.
The country's health establishment appears to
have beeh the target of both sides. The terrorists took
their toll, but some physicians opposed the military
government after the coup, and a few were reported
to have helped set up and run clandestine hospitals to
treat wounded terrorists. That may be one reason, or
excuse, for any continued harassment of physicians.
For some reason, psychiatrists seem to be high on the
current military hit lists.
Henry Kaplan, professor of radiation at Stanford
Univ., was one of the leaders of the effort in the U.S.
to boycott the Congress in protest of Argentine
human rights violations. He was a member of a dele-
gation which went to Buenos Aires before the Con-
gress in an attempt to personally present their case
to the government.
Kaplan said the delegation had been promised an
interview with the Argentine minister of the interior;
but when they arrived, the interview was refused. The
delegation turned over a list of 185 nar+.-,es of doctors
who allegedly had been arrested and held without bail
or trial to UICC President Pierre Denoix, along with a
letter to the government as}:ing that ihtsP nerconc
either be released or given an early, fair and open
trial.
Denoix told The Cancer Letter that he had for-
warded the letter and the list of names to the govern-
ment.
Kaplan said that Amnesty International and other
organizations have obtained the names of about
5,000 victims of the government's persecution-all
arrested or disappeared since the coup in 1976. He
said conversations with members of families of
victims and other sources indicate that there are from
three to five additional victims for each one whose
name is known.
Many U.S. Congress participants attended a mass
held for persons who have disappeared, talked with
family members afterwards and were greatly moved.
The boycott probably did not affect attendance
too much, although it may have cut into the size of
the U.S. delegation somewhat. It was obvious, how-
ever, th:.t it did embarrass to some extent both the
Argentine government and Argentine cancer program
officials. The boycott most certainly added to other
pressures which have been exerted on behalf of
human rights in Argentin:a.
r,... I

rhe Buenos Aires Herald, an English language dail)
run by a courageous editor, Robert Cox, published
an editorial during the Congress calling orp the govern-
ment to stop "another form of terrorism."
Referring to lifting of economic sanctions and
possible removal of the ban on sale of armaments by
the U.S. to Argentina, the editorial said:
"The material incentives for removing the human
rights stumbling block, which has been the cause of
tensions in relations with the U.S. for over two years
now, are not to be sneezed at. But there is much
more to be gained in moving decisively and rapidly to
improve the human rights situation in Argentina. The
fact is that there is hardly a single leading Western
country, among Argentina's traditional friends, allies
and trading partners, which does not share U.S. con-
cern about the state of human rights in this country.
It would be difficult to over-estimate the favorable
impact of measures that would clear up misunder-
standings about the government's efforts to put a
stop to the violation of human rights begun by the
leftwing terrorists and, unfortunately, carried on by
another form of terrorism.
"The admitted excesses in repression committed in
the heat of battle, in the course of a dirty, unconven-
tional war, are understandable, even if they can never
b: justified. But now that the war against terrorism is
won, and the major danger is the isolated atrocity
committed by inhuman fanatics, the methods which
were forced upon the security forces-or tolerated by
them-must be replaced by strict law enforcement.
Argentina today has antiterrc.rist laws wliich are
among the most severe in the world; but they have
yet to be rigorously applied. Yet it is only through
imposing the law that confidence in the future can be
res:ored.
"There have been a few i:idications. recently, that
peace is being won in the wake of a truly ~ terrible war
during which Argentina suffered a terrorist assault
which is probably unparalleled in history. Our critics
abroad would understand our difficulties in restoring
peace more easily if they bore that in mind. Within
the past fortnight, Enrique Esteban, a journalist who
was kidnapped and held for over two months in cir-
cumstances that bore all the hallmarks of what has
been called "the other terrorism." has reappeared and
is being held, under specific charges, within the penal
system. And in Cordoba, the abduction of another
journalist and lawyer, Luis Renaudi, by unidentified
men wearing hoods, was followed by an announce-
ment that lie and five other people were being held
by the Army. In this case it is unfortunate that no
specific charges have been announced and the de-
tained people have not been brought before a iudge.
But both these incidents-as well as the rapid release
somr 10 days ago of a doctor who was kidnapped by
men posing as policemen-are signs that normality is
gradually rcturning to a country that is still uncertain
that heace has finally been restorcd after almost a
decade of terrorist warfare."
Lest anyone conclude that publishing this editorial
in an English;ang;;age newspaper in a Spanish speak-
ing country might not have been such a bold act
after all, it should be noted that the editorial was re-
peated on the same page-in Spanish.
RFA ANNOUNCEMENT
Title: Planning model cancer prevention programs
at the community level
The Div. of Cancer Control & Rehabilitation of
NCI is inviting grant applications from investigators
to develop cancet prevention programs in environ-
mental carcinogenesis.
In view of the exposure of sizeable populations to
both environmental and occupational carcinogens,
the intent of this RFA is to stimulate interest and
planning of cancer prevention programs at the com-
munity level. Among its objective3 are the identifica-
tion of community needs in cancer prevention fol-
lowed by development of approaches for meeting
these needs that can serve as models for future
efforts. The community is defined here as the area
within which the programs will be implemented, that
is, the program delivery and impact area. Since DCCR
is precluded from supporting basic or clinical research
except in reaabilitation, approacl}es should utilize or
adapt existing knowledge and technology relating to
cancer prevention and control. Prevention is being
defined here in its broadest sense, ranging from elimi-
nation of exposure where possible to detection and
diagnosis and includes public and professional educa-
tion programs.
1i'hat is desired is the application of the principles
of preventive medicine to community needs in the
prevention of cancer. Such programs, to be effec:ive
and well coordinated, should utilize multidisciplinary
approaches and should involve the cooperation of
institutions, organizations, and interested groups
within the community. Organizations responding
should have established oncology and preventive
medicine programs.
Applicants should address all of the following
points, although support is not limited to items:
1. A specific and well defined environmental or
occupational cancer prevention problem. An example I
would be a population exposed to environmental car-
cinogens that are amenable to development of a pre-
vention program. A brief description should be in-
cluded covering present knowledge of exposed popu- I
lation, such as its cancer incidence, morbidity and
mortality, extent of exposure, demographic charac-
teristics. etc., and methods by which additional in-
formation will he collected and utilized.
2. Brief description of possible approaches to the I
solution of the problem. The proposed strategies
should utilize or adapt known methods and proce-
dures and, where indicated, new approaches to the
Page 5 l Vol. 4 No. 42 The CltnGer Let r
!~r N ~t~~i

particular problem should be identified. Among the
components that might be considered in developing
strategies are: epideht°ology, worker and corrtmunity
professional educational programs, detection and
diagnosis, etc. Other points for consideration in de-
velopinF a prevention program could be: how to in-
form people that they might be at risk, where they
should go once they are informed, and defining corn-
munity responsibilities in a program of this type. The
proposed plan should describe and utilize available
resources in the community. In addition to health
organizations and services, the program planning
efforts should involve other types of community
groups, such as labor organizations, business and pro-
fessional groups, etc.
It must be emphasized that DCCR supports demon-
stration programs, rather than those of long term
duration. Therefore, mechanisms for obtaining long
term support should be included in all programs in-
tended to continue indefiritely. and development of
long term institutional commitments to the program
should be included as part of the plan.
3. Description of the evaluation plan. An evalua-
tion component must be built into all prevention
programs. The plan should address evaluation of the
day to day activities as well as the impact of the pro-
gram ay eutlined in the statement of prograrr) goals
and objectives. Included should be a timetable and
suggested milestones.
Award of a grant under this solicitation to a given
institution or organization neither implies nor guaran-
tees favorable action on any subsequent application
for a demonstration grant. Only applications for
planning grants will be considered under this solicita-
tion.
The support mechanism for this program will be
the traditional NIH grant-in-aid: successful applicants
will plan and execute their own programs. Upon initi-
ation of the program, the DCCR will sponsor two
workshops in Bethesda to encourage exchanges of in-
formation between investigators participating in this
program. Although this program is included and pro-
vided for in the financial plans for fiscal year 1979,
award of grants pursuant to this request for applica-
tions is contingent upon availability of funds for this
purpose.
The following will not be considered under the
scope of this RFA:
-Programs where the primary emphasis is mass
screening, e.g., breast and cervical cancer screening
projects.
-Development of tumor reFistr.es.
Review criteria-The factors consi4.ered in evalu-
ating each application uili be:
1. Relevance to the scope and objectives provided
in this announcement.
2. The merit of the proposed approaches to the
problem.
3. The expertise and qualifications of the pro-
The Cancer Letter Oct. 20, 1978 / Page 6
posed staff.
4. Sufficient commitment of time by the pro-
posed staff.
5. Evaluation plan and tin-etab:e.
Method of applying-Each prospective applicant
should submit a letter of intent containing a brief de-
scription of the proposed project. Due dates are:
Letters of intent: Feb. 1, 1979 and June 1, 1979,
Applications: March 1, 1979, and July 1, 1970.
In addition to the solicitation dates listed, qpplica-
tions already in preparation will be considered for the
Nov. 1, 1978 deadline.
The letter of intent should be addressed to Marcia
Litwack, program director for prevention, NCI,
Room 719, Blair Bldg., Bethesda, Md. 20014, dele-
phone 301-427-7993.
Such letters provide an indication of the number
and nature of applications, are not binding, and will
not enter into the review of any proposal submitted.
Applications should be submitted on Form PHS-
398. The conventional presentation for grant applica-
tions should be utilized and the points identified
under the Review Criteria must be fi;ifilled.
The standard procedures for submitting grant
applications to DRG should be followed. A brief
letter should accompany the application indicjating
that it is in response to the program announceiineat:
NCI program development of model cancer pneven-
tion programs. The words, "Cancer Control" and the
RFA number should be typed in block letters iht the
upper right hand comer of the first page of the appli-
cation. A copy of the covered letter should be sent to
Litwack to indicate that the application has been
submitted.
RFPs AVAILABLE
Reqv -sts for proposal described here oertain to corir3rctY
planned for award by the National Cancer Institute, unless
otherwise noted. Write to the Contracting Officer or Ccntract
Specialist for copies of the RFP, citing the RFP number. Some
listings will show the phone number of the Contract Specialist
who will respond to questions. Listings identify the re,spective
sections of the Research Contracts Branch which are issuing
the RFPs Their addresses, all followed by NIH, Bethesia,
Md. 20014, are:
Bioiogy & Diagnosis Section - Landow Building
Viral Oncology & Field Studies Section - Landow Building
Control & Rehabilitation Section - Blair Building
Carcinogenesis Section - Blair Building
Treatment Section - Blair Building
Office of the Director Section - Blair Building
Deadline date shown for each listing is the final day fdr re,
ceipt of the completed proposal unless otherwise indicated.
SOURC:ES SOUGHT
RFP NCI-CI1R97235
Title: Operation and enhancement oj.%'C!'s rhemi-
cal infor;tration s.rstem
Deadline: Appru.vimaielr ,\'ot. I
Only one source is known which can perform the
abme.mtnlev. the Chemical Abstracts Services.

Columbus, Ohio. The work required is to support
the drug research and development effort of the Div.
of Cancer Treatment, NCI, by operating and en-
hancing the developmental Therapeutics Program's
chemical information system.
Specifically, respondents will be required to per-
form the following: (1) Review 53,500 structural
diagrams yearly to assure conformance with CAS
input conventions, including steriochemistry, and
input these structural data by chemical typewriter or
graphic input device along with non-structural data;
(2) process the data in (1) above with other type of
transactions to produce 2-odd reports within 10
working days from receipt of input; (3) provide
Chemical Abstracts index names "on-demand" and
produce periodically an index of non-systematic
names selected from both the NCI and CAS cotn-
puterized filet of nomenclature; and (4) perform a
variety of development tasks, e.g., providing consul-
tation and programming support to improve NCI's
acquisition preselection model or to enhance the
chemical retrieval subsystem:
The applications programming for this system
employed PLI and IBM 360/70 Assembler Language.
Supporting software includes the IBM TCAM package
with a device and application specific control module,
a custom-tailored data base management system, a
customized pre-processor, graphics interface modules
and device specific modules for editing of input data
and preparation of combined text/graphics output
data. The on-line program, supporting three terminals
(and possibl% . four in the immediate future) during
prime shift. is non-re-entrant and each copy requires
a region of 1.2 megabytes. In addition to the on-line
programs, the system currently calls for the execu-
ticn of over '_6G programs each week, not including
file snapshots and file recwvery supporting pro-
cedures.
The followang software developed by CAS has
been integrated into NCI's chemical information sys-
tem and will require transfer to and maintenance and
enhancement in any new work environment: Regis-
try III. Algorithmic Structure Display (ASD), On-
Line Structurr Input System (OLSIS), Graphical
Data Structure Composition (GDS Comp). Overlap
Detection, and Facility for Integrated Data Organiza-
tion (FIDO). The computer facility must be capable
of processing programs written in PLl and IBAi
A.ssembler language ranging in size up to 1.2 mega-
bytes, excluding a shared resident data base manage-
ment system. Provision must be made for on-line
telecommunication access to 600 million bytes of
data. Output devices must include a line printer with
an extended character set. a combined text/graphics
plotting device. and a photocompos"tion device
capable of generating a virtually unlimited character
set. Input devices must include a text (TTY) type-
writer and also a typewriter and/or graphics input
dc% ik:c for the inrut of chemical structure diagrams.
Cursk'nt programming within this system also requires
that the typewriter input devices be linked to a mini-
computer system for data editing prior to input of
that data to the central system.
Organizations having demonstrated technical capa-
bilities, eitperience, and adequate facilities to perform
the aforementioned work are invited to submit a
concise and complete resume describing: (1) organi-
zation background and experience; (2) qualification
and experience of the proposed principal investigator
and supporting personnel who would be assigrled to
the project; and (3) computational resources avail-
able. Unnecessarily elaborate brochures or other pre-
sentations of a general nature beyond that sufficient
to provide the information called for herein are
neither required nor desired. This synopsis is not a
request for proposal. If other qualified sources are
identified as a result of this announcement, a com-
petitive RFP will be issued at a later date to all inter-
ested offerors. Responses must be submitted in 10
copies.
Contracting Officer: Daniel Abbott
Cancer Treatmen t
301-427-8125
RFP tVCI-CB-9432G-42
Title: Transpiantation, induction, and preservatiorr
of plasma cell tumors in mice and the mainte-
nance of special mouse strains
Deadline: Approxintately Nov. 10
NCI is seeking a laborator, capable of perfonnitig:
{ 1) the transplantation, induction and preservation
of plasma cell tumors in mice, (2) the charactcr,za-
tion of myeloma proteins, (3) the breeding and de-
velopment of congenic mouse strains, and (4) the
maintenance of a wild mouse breeding colony These
studies are to be performed in close collaboration
with the NCI staff. The contractor's facility must be
within a 60-minute normal driving time from the
NIH campus in Bethesda, Md. This project is a re-
competition of a project presently under contract.
RFP NCI-CB-9432542
Title: Alaintenance arrd development of inbred and
congenic resistartt mouse strains
Deadline: Approxi.nately Nor. 10
NCI is seeking a laboratory capable of (I) main-
taining a colony of approximately 40 strains of in-
bred mice by strict pedigreed brother-sister matings,
(2) breeding and developing new congenic mouse
strains. (3) making selective crosses and backerosses
between these strains, (4) producing antisera by
immunization between these strains, and (5) per-
forming quality control testing by serology and skin
grafting of oedigreed animals in the colony. A maxr
mum of 3,000 mice (to be supplied by the govern-
men() will be maintained under this contract. The
contractor's facility must be within a 60-minrte
Page 7 / Vol. 4 Na. 42 y'~~ apcer

t
normal driving time from the NIH campus in Bethes-
da, Md. This project is a recompetition of a project
currently under contract.
Contracting Officer for
the above two RFPs: Harold Simpson
Biology & Diagnosis
301-496-5565
NCI CONTRACT AWARDS
Title: Comprehensive cancer center communica-
tions netvrork, renewals:
Contractors: Yale Univ., S489,96 1; Institute for
Cancer Research, Fox Chase, $453,790; Univ.
of Texas Cancer Center, 5473,366; Univ. of
Southern California, 5439,419; Ohio State
Univ. Research Foundation, 5387,473;
Sidney Farber Cancer Institute, S463,881;
Mayo Foundation, S496.698; Fred Hutchin-
son Cancer Research Center,S394,930,and
Johns Hopkins Univ., S421,491.
Title: Comprehensive cancer center communica-
tions network. four-month extension:
Contractor: Colorado Regional Cancer Center,
S'_9.189.
Title: Breast Cancer Deteaion Demonstration
Project. renewals:
Contractors: University City Science Center, Phila-
delphia. 52,016,500; Univ. of Southern Cali-
fornia, $83,083, and Iowa Lutheran Hospital.
Des Moines, S 131,296.
Title: lntenelationships among diet, steroid hor-
mone metabolism and human breast cancer
Contractor: Newark Beth Israel Stedicsl Center,
S4'_5,100.
Title: Relationship between thyroid diseases and
breast cancer
Contractor: Massachusetts General Hospital,
5477,700'.
Title: Development of large area solid state image
receptors, continuation
Contractor: General Electric Co., $279,185.
Title: Biologic, biochemical & immunologic charac-
terization of 'premalignant' human epithelial
ltyperplaslas
Contractor: Univ. of California (Davis), 5257,000.
Title: Cervical Cancer screening project, modifica-
tion
Contractor: Utah Dept of Social Services, S'_'95,531.
Title: Evaluation of technology !ransfer in cancer
patient management
Contractor: CDP Associates, $256,821.
r
Titlea Additional services and effort for perfor-
mance of cancer research program at Fred-
erick Cancer Research Center, modification
Contractor: Litton Bionetlcs~ S 105,000.
Titler Resources modeling and analysis
Contractor: JRB Associates, $230,769.
Title: Development of a short training course on
principles and techniques for the safe hand-
ling of chemical carcinogens, renewal
Contractor: IIT Research Ins4itute, 521,520.
Title: Support services for Field Studies of cancer
incidence, continuation
Contractor: Westat Inc., $127,997.
Title: Support services for epidemiologic studies of
lung cancer in communities with nonferrous
smelters
Contractor; Lehigh Univ., S1.-'_,900.
Title: FDA/KCI special study of the role bf sac-
charin in bladder cancer in the general popu-
lation, continuation.
Contractor: Westat Inc., S2 17,409.
Title: Research on oncogeaic viruses, virus prcduc-
tion and vaccine development, continuation
Contractor: Merck & Co., 566,000.
Title: Biological studies of FOCAtA expression and
biochemical characterization of FOCMA
Contractor: Harvard Univ., 5415,830.
Title: Study of ovarian cancer in the Greater Wash-
ington D.C. area
Contractor: George Washington Univ., S89,385.
Title: Immunological and biochemical studies of
mammalian vira! oncology, continuation
Contractor: Meloy Laboratories, $49,513.
Title: Metropolitan Atlanta SEER program, con-
tinuation
Contractor: Emory Univ., S207,460.
Title: Support service to maintain studies on role of
viruses and experimental oncogenesis, continu-
ation
Contractor: Hazelton Laboratories, $44,000.
Title: Detroit SSMA population based cancer regis-
try. continuation
Contractor: Michigan Cancer Foundation, 560,095.
Title: Maintain holding facility for small animals
Contractor: Litton Bionetics, S258,'' l5.
Title: Benign and non-invasive breast lesions in
populations at different risk for breast
cancer
Contractor: Univ. of New Mexico, 5278,350.
4hfa CanCe1''° Ll14@ P_Ediror JE R RY D. BOYD
Published fifty times a year by The Cancer Letter. Inc.. P.O. Box 2370. Reston. Virginia 22090. All
rights reserved. None of the content
of this publication may be reproduced, stored in a retrieval system, or transmitted n any form or by
any means (electronic. methanical.
photocopying, recording or otherwise) without the prior written permissron of the publisher. 1
3lf/!.Y~4
E Z 1V
